Letrozole and ribociclib can be part of a treatment plan for hormone receptor-positive (HR-positive), HER2-negative breast cancer, but not typically for HER2-positive cases. HER2-positive breast cancer is often treated with targeted therapies like trastuzumab or pertuzumab, sometimes combined with hormone therapy if it's Show Full Answer

Letrozole and ribociclib can be part of a treatment plan for hormone receptor-positive (HR-positive), HER2-negative breast cancer, but not typically for HER2-positive cases. HER2-positive breast cancer is often treated with targeted therapies like trastuzumab or pertuzumab, sometimes combined with hormone therapy if it's also HR-positive. Always consult your oncologist to confirm the best treatment plan for your specific case.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

6 HER2-Positive Breast Cancer Treatments: Chemotherapy and More | MyBCTeam

Letrozole vs. Anastrozole for Breast Cancer: A Comparison | MyBCTeam